|
1) Norgren L, et al. on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45: S5-67
|
|
|
|
2) Kudo T, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006; 44: 304-13
|
|
|
|
|
|
3) Schillinger M, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006; 354: 1879-88
|
|
|
|
|
|
4) Scheinert D, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005; 45: 312-5
|
|
|
|
|
|
5) Tepe G, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008; 358: 689-99
|
|
|
|
|
|
6) Scheinert D, et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001; 8: 156-66
|
|
|
|
|
|
7) Laird JR, et al. Peripheral excimer laser angioplasty (PELA) trial Results. Transcatheter Cardiovascular Therapeutics (TCT), September. 24-28, 2002
|
|
|
|
|
|
8) Laird JR, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006; 13: 1-11
|
|
|
|
|